Pharmacogenetics of human cytosolic sulfotransferases
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Cytosolic sulfotransferases (SULTs) are phase II detoxification enzymes that are involved in the biotransformation of a wide variety of structurally diverse endo- and xenobiotics, including many therapeutic agents and endogenous steroids. Single-nucleotide polymorphisms (SNPs) in SULTs have functional consequences on the translated protein. For the most part, these SNPs are fairly uncommon in the population, but some, most notably for SULT isoform 1A1, are commonly found and have been associated with cancer risk for a variety of tumor sites and also with response to therapeutic agents. SNPs in the hydroxysteroid sulfotransferase, SULT2A1, have been identified in African-American subjects and influence the ratio of plasma DHEA:DHEA-S. This modification could potentially influence cancer risk in steroidogenic tissues. SNPs in many SULTs are ethnically distributed, another factor that could influence SULT pharmacogenetics. Finally, genetic variation has also been identified in 3'-phosphoadenoside 5'-phosphosulfate synthetase (PAPPS), the enzymes responsible for producing the obligatory cosubstrate for all sulfotransferases. Taken together, this variability could substantially influence the disposition of drugs metabolized by SULTs. Elucidation of the basis and effect of variability in sulfation could greatly impact individualized therapy in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“African-Americans have a high rate of polymorphisms in SULT2A1 apparently influencing plasma ratios of DHEA: DHEAS, which may correlate with the risk of prostatic and other cancers (603).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [603]
Citations
Cites
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129 · cited 1×
“Tamoxifen has been the gold standard of endocrine therapy for breast cancer since the 1970s (1985; 1986; Mariotto et al., 2002) and its use has contributed significantly to the decline in breast cancer mortality (Love et al., 1992).”
BackgroundSulfotransferases in the bioactivation of xenobiotics
Glatt, H. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00202-7 · Cited by 354 · cited 1×
“To date, at least 11 different SULT enzymes have been identified (reviewed in Glatt, 2000).”
BackgroundThe effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Raftogianis, R. B., Wood, T. C., Otterness, D. M., Van Loon, J. A., & Weinshilboum, R. M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7466 · Cited by 305 · cited 1×
“These SNPs were in linkage disequilibrium with each other and with an SNP at 638, which is responsible for an aminoacid change from arginine to histidine at residue 213 (Raftogianis et al., 1997; Ozawa et al., 1998).”
BackgroundTyrosine Sulfation and the Secretory Pathway
Huttner, W. B. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002051 · Cited by 263 · cited 1×
“SULTs involved in Phase II biotransformation of endoand xenobiotics are cytosolic, although there are membrane bound SULTs that are responsible for catalysing the sulfation of protein tyrosyl residues and polysaccharides (Huttner, 1988; Hashimoto and Hirschberg, 1992).”
BackgroundGenotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
Wegman, P., Vainikka, L., Stål, O., Nordenskjöld, B., Skoog, L., Rutqvist, L.-E., & Wingren, S. (2005) · Breast Cancer Research · doi:10.1186/bcr993 · Cited by 243 · cited 1×
“A subsequent study in the context of a clinical trial also indicated the same trend of better overall survival associated with the SULT1A1*1 allele (Wegman et al., 2005) in patients treated with tamoxifen.”
ResultAdjuvant Chemotherapy for Breast Cancer
BLOMQVIST, C. P. (1985) · JAMA · doi:10.1001/jama.1985.03360240073038 · Cited by 237
Pharmacogenetics of Sulfotransferase
Nagata, K., & Yamazoe, Y. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.159 · Cited by 215 · cited 1×
“SULT pharmacogenetics have been the subject of two recent reviews (Nagata and Yamazoe, 2000; Glatt and Meinl, 2004).”
BackgroundKhetawat, G., Faraday, N., Nealen, M. L., Vijayan, K. V., Bolton, E., Noga, S. J., & Bray, P. F. (2000) · Blood · doi:10.1182/blood.v95.7.2289 · Cited by 210
Parker, C. R. (1999) · Steroids · doi:10.1016/s0039-128x(99)00046-x · Cited by 201 · cited 1×
“Humans synthesize large amounts of DHEA-sulfate during fetal development and after adrenarche (Parker, 1999).”
Background
Research works printed but not linked: 2
- Falany CN, Wheeler J, Oh TS, Falany JL . (1994b). J Steroid Biochem Mol Biol 48: 369–375. · DOI · Paper page
- Wilborn T, Lang N, Smith M, Meleth S, Falany C . (2005). J Steroid Biochem Mol Biol, in press.
Cited by
Items 101–162 of 162
Obara, A., Kinoshita, M., Hosoda, K., Yokokawa, A., Shibasaki, H., & Ishii, K. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.478 · Cited by 11
Small-molecule control of neurotransmitter sulfonation
Cook, I. T., Cacace, M., Wang, T., Darrah, K. E., Deiters, A., & Leyh, T. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015177 · Cited by 10
“v 1⁄4 Vmax ⋅ ðC1 ⋅ KiB þ αB ⋅ 1⁄2B Þ=ðC2 ⋅ KiB þ 1⁄2B Þ (11)”
BackgroundWang, Y., Juang, G., Hwang, T. I.-S., Shen, C., Shao, K.-Y., & Chiou, H. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02166.x · Cited by 9
Dzakovich, M. P., Goggans, M. L., Thomas‐Ahner, J. M., Moran, N. E., Clinton, S. K., Francis, D. M., & Cooperstone, J. L. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300239 · Cited by 9
Whitehouse‐Tedd, K., Cave, N., Ugarte, C. E., Waldron, L. A., PRASAIN, J. K., Arabshahi, A., Barnes, S., Hendriks, W. H., & Thomas, D. G. (2013) · Journal of Animal Science · doi:10.2527/jas.2011-4812 · Cited by 9
Abunnaja, M. S., Alherz, F. A., Daibani, A. A. E., Bairam, A. F., Rasool, M. I., Gohal, S. A., Kurogi, K., Suiko, M., Sakakibara, Y., & Liu, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0341 · Cited by 9
Singh, N., & Singh, A. K. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128780 · Cited by 8
Hsu, C.-C., Lu, L.-Y., & Yang, Y. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003601987 · Cited by 8
“Sulfation, a widespread biological reaction, is catalyzed by sulfotransferase [9,10].”
BackgroundTibbs, Z. E., Guidry, A. L., Falany, J. L., Kadlubar, S. A., & Falany, C. N. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1282646 · Cited by 8
Self-citationMethamphetamine regulation of sulfotransferase 1A1 and 2A1 expression in rat brain sections
Zhou, T., Huang, C., Chen, Y., Xu, J., Shanbhag, P. D., & Chen, G. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.09.010 · Cited by 7
“Although SULTs are most highly expressed in the liver, they are present in many tissues, including the small intestine, brain, adrenal gland, kidney, skin, blood platelets and nucleated blood cells (Alnouti and Klaassen, 2006, Nowell and Falany, 2006, Richard et al., 2001).”
Backgrounddos Santos, S. S. M., Koifman, R. J., Ferreira, R. M., Diniz, L. F., Brennan, P., Boffetta, P., & Koifman, S. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00183 · Cited by 7
“The sulfotransferases (SULTs) are phase II detoxification enzymes involved in the biotransformation of a wide variety of xenobiotics and endogenous steroid (Nowell and Falany, 2006).”
BackgroundInteractions of Betel Quid Constituents with Drug Disposition Pathways: An Overview
Myers, A. L., & Canlas, J. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230228142052 · Cited by 6
Cardoso-Filho, C., Sarian, L. O., de Oliveira, C. B. M., Bossi, L. S., Lourenço, G. J., Lima, C. S. P., & Gurgel, M. S. C. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2221-y · Cited by 7
“Active tamoxifen metabolites become inactivated by conjugation via phase 2 liver enzymes [10–12].”
BackgroundExpression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder
Svoboda, M., Sellner, F., Ekmekçioğlu, C., Klimpfinger, M., Jaeger, W., & Thalhammer, T. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.03.007 · Cited by 6
Pharmacogenomics and Personalized Medicine
Li, J., Bluth, M. H., & Ferreira‐Gonzalez, A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00072-5 · Cited by 7
Disposition of Flavonoids for Personal Intake
Liu, S., Zheng, H., Sun, R., Jiang, H., Chen, J., Yu, J. H., Zhang, Q., Chen, Q., Zhu, L., Hu, M., et al. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0095-0 · Cited by 7
Rohn‐Glowacki, K. J., & Falany, C. N. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0028 · Cited by 5
“SULTs are phase II conjugating enzymes that are involved in the metabolism of many endogenous compounds and xenobiotics [18].”
BackgroundSelf-citationToxicokinetics: Biotransformation of Toxicants
Kedderis, G. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.01888-2 · Cited by 5
Decosterd, L. A., Dahmane, E., Neeman, M., Buclin, T., Csajka, C., Haouala, A., & Widmer, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3828-1_9 · Cited by 4
Wang, Y., Peng, L., Lu, H., Zhang, Z., Xing, S., Li, D., He, C., Jin, T., & Wang, L. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s327313 · Cited by 4
“The latter are phase-II detoxification enzymes and have a crucial role in the metabolism of several xenobiotics and endogenous compounds (eg, tamoxifen).(30,31) High polymorphism of SULT1A1 has been reported among Caucasian, Chinese, African– American and Korean populations.”
Background2-Naphthalenemethanol participates in metabolic activation of 2-methylnaphthalene
Li, K., Zou, Y., Wang, Y., Zhou, M., Li, J., Tan, R., Zhang, S., Li, W., & Zheng, J. (2022) · Xenobiotica · doi:10.1080/00498254.2022.2079022 · Cited by 4
“Specifically, SULTs catalyse the transfer of sulphate to amino, hydroxyl, or N-oxide groups (Nowell and Falany 2006; Kurogi et al. 2021).”
BackgroundPython metabolomics uncovers a conserved postprandial metabolite and gut–brain feeding pathway
Xiao, S., Wang, M., Martin, T. G., Scott, B., Fang, X., Liu, X., Yang, Y., Fu, S., Truong, S. D., Gugel, J. F., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01485-0 · Cited by 3
“Sul-fotransferases (SULTs) are a class of enzymes that catalyse metabolite sulfation and exhibit liver-enriched expression 26 .”
Duffel, M. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00005-x · Cited by 3
Nuclear Receptor‐Mediated Regulation of Phase II Conjugating Enzymes
Barbier, O. (2008) · Wiley eBooks · doi:10.1002/9780470409107.ch3 · Cited by 3
Duffel, M. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95623-x · Cited by 3
Drug Metabolism in Gastrointestinal Tract
Singh, R., & Hu, M. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch8 · Cited by 2
Chetrite, G. S. (2008) · CRC Press eBooks · doi:10.3109/9781420058734-3 · Cited by 2
Heterocyclic aromatic amines (HAA), exposure, metabolism, macromolecular adducts, and cancer risk
Bellamri, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00717-x · Cited by 2
Analysis of evolutionary and functional features of the bullfrog SULT1 family
Sato, K., Yamauchi, K., & Ishihara, A. (2023) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2023.114349 · Cited by 1
Aromatic Amines, Aromatic Amides, and Heterocyclic Aromatic Amines
Turesky, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00193-5 · Cited by 1
Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells
Pall, M., Nguyen, M., Magoffin, D. A., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.049 · Cited by 1
SULT1A1 copy number variation: ethnic distribution analysis in an Indian population
Almal, S. H., & Padh, H. (2017) · Annals of Human Biology · doi:10.1080/03014460.2017.1376852 · Cited by 1
The role of biotransformation in the estrogenicity of xenobiotics
Reinen, J. (2010) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1
Ma, B., & Schrag, M. L. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm016 · Cited by 1
Martínez, M. M., Cerpa, L. C., Varela, N., & Quiñones, L. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_126-1 · Cited by 1
XENOSENSOR REGULATION OF ENZYMES AND TRANSPORTERS IN DRUG EXPOSURE AND DISEASE
Merrell, M. D. (2011) · UA Campus Repository (The University of Arizona)
Jimenez-Canet, M. (2014) · UA Campus Repository (The University of Arizona)
Bhathena, A., & Katz, D. A. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm082
Major Human Conjugative Drug‐Metabolizing Enzymes
Albaugh, D., & Fisher, M. B. (2014) · Wiley eBooks · doi:10.1002/9781118541203.xen0013
Ekuase, E. J., Duffel, M. W., Rice, K. G., Kerns, R. J., Doorn, J. A., & Robertson, L. W. (2011) · doi:10.17077/etd.ak7rq9zn
NEW APPROACHES IN UNDERSTANDING DRUG METABOLISM
Hart, S. N. (2011) · KU ScholarWorks (University of Kansas)
Peptidyl-Prolyl Cis-Trans Isomerase Pin1
Choi, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_102849
Martínez, M. F., Cerpa, L. C., Varela, N., & Quiñones, L. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_126
Drug Metabolism in Gastrointestinal Tract
Singh, R., Bui, D., & Hu, M. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch11 · Cited by 1
An Introduction to Toxicokinetics and Biotransformation
Watkins, J. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00014-0
Griffin, A. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)
Chemical Tools to Inhibit and to Modify Proteins
Cacace, M. (2024) · D-Scholarship@Pitt (University of Pittsburgh)
Abunnaja, M. S. (2019) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Daibani, A. A. E. (2018) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Zhang, W., Peng, J., Dai, D., Huang, C., Liu, F., & Chen, X. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04659-y
“Similarly, the phosphatidylinositol 3-kinase (PI3K)/AKT pathway is commonly activated in HCC and drives cell growth, survival, and metabolic reprogramming [11].”
Yao, X., Li, N., Liu, Y., Malhi, K. K., Zhang, T., Zhao, Y., Li, H.-X., & Li, J. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3087-9
Delannée, V. (2017) · theses.fr (ABES) · doi:10.70675/010f60d5z3d06z4eadz831az2edcdae592fa · Cited by 1
Age-dependent transcriptional remodeling of the liver and gallbladder in response to fasting in mice
Lu, Y., Ying, P., Song, J., 丁婉琦, Feng, P., Du, J., Ruan, C., & Liu, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-48575-3
“This is consistent with the increased expression of sulfotransferases such as Sult3a1 and Sult3a2 , which are known to be developmentally regulated and contribute to the metabolic handling of endogenous and exogenous compounds 14,15 .”
Xin, Y., Wang, Q., Wang, S., Chang, Y., Liu, G., Duan, Y., Zhu, J., & Li, X. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100326
Developmentally Regulated Expression and Activity of Sulphotransferases in the Rat Choroid Plexuses
Qiu, F., Strazielle, N., Denuzière, A., & Ghersi‐Egea, J. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70533
“…membranes not only via increased hydro-philicity, but also by action of ATP-binding cassette (ABC) efflux transporters that recognise compounds conjugated to a transport motif such as sulphate, glutathione and glucuronate following phase II metabolism (Nowell and Falany 2006; Zhou et al. 2008).”
Codeluppi, M., Tosi, N., Pedroni, L., Perugino, F., Bragazzi, N. L., Bresciani, L., Rio, D. D., Mena, P. R., & Dellafiora, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-65193-1
“This enzyme shows the highest hepatic expression among SULT1 members 10 and may act on a broad variety of substrates with specificity for small molecules like low-molecular-weight (poly)phenols, drugs, and hormones 11,12 .”
Intermolecular interactions of CYP3A enzymes and cytosolic sulfotransferases (SULT1E1, SULT2A1)Preprint
Tumilovich, A., Yablokov, E. O., Gnedenko, O. V., Mednaya, D. M., Selin, V., Mezentsev, Y. V., Ершов, П. В., Kaluzhskiy, L. A., Tsybruk, T. V., Grabovec, I. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.14.759113
BindingDB Entry 7764: High accuracy in silico sulfotransferase models.
BindingDB (2017) · UC San Diego · doi:10.7270/q2xp73s3
Metadata
- Authors
- Nowell, S., & Falany, C. N.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Nowell, S
- Falany, C N
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 11
- Pages
- 1673-1678
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2058380077
- Semantic Scholar
- 4a231f71813b6ba42e0f4860c32817dcb237908f
- Cited by
- 158
- References
- 49
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 11 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 15
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- cytosolic sulfotransferases, SULT1A1, SULT2A1, hydroxysteroid sulfotransferase, single nucleotide polymorphisms, genetic variation, cancer risk, drug metabolism, sulfation, 3'-phosphoadenosine 5'-phosphosulfate, personalized treatment, phase II enzymes
- MeSH terms
- Antineoplastic Agents, Black or African American, Ethnicity, Humans, Isoenzymes, Neoplasms, Pharmacogenetics, Sulfotransferases, Arylsulfotransferase, Xenobiotics, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.